By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bayer Schering Pharma 

M├╝llerstrasse 172- 178

Berlin    D-13342  Germany
Phone: 49-30-468-11-11 Fax: 49-30-468-15305




EPIX Pharmaceuticals, Inc. 

Company News
Lead Discovery Center and Bayer Schering Pharma Enter Into License Agreement Covering a Novel Pharmaceutical Lead Structure 4/19/2011 9:58:55 AM
Bayer Schering Pharma Partners with NPERC on Drug Delivery 11/9/2010 12:54:42 PM
Micromet to Advance BiTE Antibody MT112/BAY 2010112 into IND-Enabling Preclinical Development Activities in Collaboration with Bayer Schering Pharma 11/8/2010 11:03:32 AM
Ligon Discovery Collaborates with Bayer Schering Pharma to Discover Potential First-in-Class Small Molecule Therapeutics 9/29/2010 8:27:48 AM
Bayer Schering Pharma Launches MS Drug Betaferon 9/28/2010 12:23:53 PM
Bayer Schering Pharma Builds China Diabetes Portfolio with SciLin Launch 9/7/2010 3:49:19 PM
Ion Beam Applications (IBA) and Bayer Schering Pharma Sign Clinical Trial Supply Agreement for Alzheimer's Disease Tracer 8/27/2010 11:44:04 AM
Bayer Schering Pharma and OncoMed Pharmaceuticals, Inc. Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics; OncoMed to Get $40 Million Upfront; up to $387.5 Million 6/17/2010 6:52:35 AM
TauRx Therapeutics Enters Collaborative R&D Agreement with Bayer Schering Pharma 6/3/2010 9:36:58 AM
Bayer Schering Pharma's Contested Cancer Drug Regorafenib Enters Phase III 5/7/2010 7:39:33 AM